Hong Kong,, March 30, 2025 / Prnewswire / – On March 30, 2025, Fosun International Limited (Hkex Stock Code: 00656) announced its annual results for the year 2024. During the period, the total turnover of the group is reached RMB192.14 billion. Its four basic subsidiaries – Yuyuan, Fosun Pharma, Fosun Insurance Portugal and Fosun Tourism Group – have generated total turnover of RMB 134.65 billionrepresenting 70.1% of the group’s total income, supported by a solid asset base.
In 2024, the benefit of group operations of the group reached 4.9 billion RMBdemonstrating stable operational fundamentals. Excluding this unique significant effect, the profit attributable to the owners of the parent equivalent to RMB0.75 billion.
During the period, revenues abroad of the group increased 6.2% in annual sliding, increasing the proportion of revenues abroad to 49.3% of total turnover. Global operations have become a new growth engine for Fosun. The group’s investment in technological innovation amounted to 6.9 billion RMB. It has established more than 20 global technological innovation centers, covering various industries and domains.
In 2024, Fosun’s operating cash flows remained healthy and stable. The divestment of signed assets rose roughly RMB 17.5 billion equivalent to the group level, and approximately RMB 30.0 billion equivalent to the consolidated level. In November 2024After an absence of three years, Fosun returned to the USD Offshore bond market and managed to issue long -term USD bonds. The International S&P credit rating agency has fully recognized the group’s constant improvement in the credit matrix and has reaffirmed the BB note and a stable credit perspective.
Show the original content:https://www.prnewswire.com/apac/news-releases/fosun-international-reports-reven-of-rmb-192-14-billion-and-industrial-operation-Profit-Of-Rmb-4-billion-in-2024-302415078.html.
Source Fosun
